Recent Intellectual Property, Patent, Trademark & Copyright News

Custom text Organization Sort descending
Mar
21
2016
No Due Process Violation Where Judgment Entered on Patents Not Asserted at Trial
Aug
2
2019
USPTO Proposes Fee Increases Across the Board
Feb
10
2014
CLS v. Alice Bank And The Cult Of The “Abstract Idea” Re: Patent Litigation
Mar
7
2014
United States Patent and Trademark Office (USPTO) Patent Eligibility Guidelines – A Step Too Far For Natural Products?
Oct
21
2019
PTO Releases New Guidelines on Subject Matter Eligibility
May
16
2016
Auto Industry Has New Weapon To Protect Its Secrets
Nov
21
2019
Nuvo Pharms. v. Dr. Reddy’s Labs. – Catch 22 at the Federal Circuit?
Jun
21
2016
Lessons For Persuading the Patent Board: Straight From Judges’ Mouths
Apr
29
2014
Natural Product Eligibility Guidelines: Isolated DNA and the “Hand of Man”
May
2
2014
In re Bergstrom – A Lost Precedent That Should Be “Found”
Jul
5
2016
USPTO will “Fast Track” Cancer Immunotherapy Applications
Jun
17
2014
Natural Products Eligibility Guidance – Post-Forum Comments
Apr
27
2020
Adjusting to Alice: USPTO Report analyzes patent examination outcomes after Alice Corp. v. CLS Bank International
Jul
2
2014
More Questions Than Answers from the Patent and Trademark Office (PTO)
Oct
12
2020
Biogen v. EMD Serono – “A Nest of Limitations”
Oct
24
2014
Section 101 at AIPLA - American Intellectual Property Law Association
Jan
18
2021
Illumina v. Ariosa – Ariosa Petitions for Cert.
May
4
2017
Par’s Hatch-Waxman Claims Too Speculative and Discovery Requests Too Broad
May
11
2021
Clearing the Air: Patent Protection Strategies for Carbon Capture Technologies
Jun
14
2021
Yu v. Apple – Transubstantiation of a Camera into an Abstract Idea
Feb
20
2015
Pacing Technologies v. Garmin – D&D Explained
Aug
3
2021
Recent Developments in Artificial Intelligence and IP Law: South Africa Grants World’s First Patent for AI-Created Invention
Sep
4
2021
Belcher v. Hospira – Inequitable Conduct is Still in Your Invalidity Toolbox
Apr
1
2011
Banning Stem Cell Research — Or Cloning? Or Both?
Apr
13
2011
Myriad Oral Arguments – Section 101 vs. Chemistry 101?
May
30
2011
Therasense Makes Sense of Inequitable Conduct Defense
Apr
8
2022
Almirall v. Amneal Pharmaceuticals – Negative Limitations II
Feb
28
2012
Bayer v. Lupin – Patenting The Label Redux
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters